U.S. Ophthalmic Photocoagulator Market Size & Outlook
U.S. ophthalmic photocoagulator market, 2016-2028 (US$M)
Related Markets
U.S. ophthalmic photocoagulator market highlights
- The U.S. ophthalmic photocoagulator market generated a revenue of USD 42.4 million in 2021 and is expected to reach USD 55.5 million by 2028.
- The U.S. market is expected to grow at a CAGR of 3.9% from 2022 to 2028.
- In terms of segment, diabetic retinopathy was the largest revenue generating application in 2021.
- Diabetic Retinopathy is the most lucrative application segment registering the fastest growth during the forecast period.
Ophthalmic photocoagulator market data book summary
| Market revenue in 2021 | USD 42.4 million |
| Market revenue in 2028 | USD 55.5 million |
| Growth rate | 3.9% (CAGR from 2021 to 2028) |
| Largest segment | Diabetic retinopathy |
| Fastest growing segment | Diabetic Retinopathy |
| Historical data | 2016 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Glaucoma, Diabetic Retinopathy, Age Related Macular Degeneration, Macular Edema |
| Key market players worldwide | Lumenis, IRIDEX Corp, Alcon Inc, Quantel Medical, Nidek Medical, Johnson & Johnson, Topcon Corp, Bausch & Lomb Corp, Meridian Bioscience |
Other key industry trends
- In terms of revenue, U.S. accounted for 27.4% of the global ophthalmic photocoagulator market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In North America, U.S. ophthalmic photocoagulator market is projected to lead the regional market in terms of revenue in 2028.
- Canada is the fastest growing regional market in North America and is projected to reach USD 13.8 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Ophthalmic Photocoagulator Market Scope
Ophthalmic Photocoagulator Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. ophthalmic photocoagulator market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic photocoagulator market will help companies and investors design strategic landscapes.
Diabetic retinopathy was the largest segment with a revenue share of 28.3% in 2021. Horizon Databook has segmented the U.S. ophthalmic photocoagulator market based on glaucoma, diabetic retinopathy, age related macular degeneration, macular edema covering the revenue growth of each sub-segment from 2016 to 2028.
Reasons to subscribe to U.S. ophthalmic photocoagulator market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. ophthalmic photocoagulator market databook
-
Our clientele includes a mix of ophthalmic photocoagulator market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. ophthalmic photocoagulator market , including forecasts for subscribers. This country databook contains high-level insights into U.S. ophthalmic photocoagulator market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. ophthalmic photocoagulator market size, by application, 2016-2028 (US$M)
U.S. Ophthalmic Photocoagulator Market Outlook Share, 2021 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
